4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001209191-23-000958
Options or other derivatives
- Chief Scientific Officer acquired 135,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wallace Owen B. Chief Scientific Officer | 2023-01-03 | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…